This inventor holds 1 USPTO granted patent. Top assignee: Hitachi Chemical Company, Ltd.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Shigeyoshi Takagi: Innovating in Equine Immunology
Introduction: Shigeyoshi Takagi is a notable inventor based in Tokyo, Japan, recognized for his contributions to equine immunology. With a keen focus on improving animal health, he has developed innovations that serve both scientific and practical purposes. His dedication to research and development has led to the filing of a significant patent.
Latest Patents: Takagi holds a patent for "DNA encoding equine interleukin-1." This invention discloses an equine interleukin-1 peptide that comprises a sequence of at least five continuous amino acids represented by SEQ ID NO: 1 or NO: 2 in the sequence listing. His patent also includes DNA coding for this peptide, a recombinant vector containing the DNA, and a transformant that hosts the recombinant vector. Additionally, the patent outlines a process for preparing an anti-equine interleukin-1 antibody, utilizing the equine interleukin-1 peptide as an antigen.
Career Highlights: Takagi is affiliated with Hitachi Chemical Company, Ltd., where he applies his expertise in biotechnology and animal health. His role exemplifies the intersection of scientific research and practical application within a leading firm in the chemical and materials industry.
Collaborations: Throughout his career, Takagi has collaborated with esteemed colleagues, including Hirotomo Kato and Noriko Nakamura. These partnerships highlight the collaborative spirit in scientific research, paving the way for advancements in equine immunology and related fields.
Conclusion: Shigeyoshi Takagi's innovative work in creating a DNA encoding for equine interleukin-1 demonstrates the vital role of inventors in bridging gaps in animal health research. His patent not only contributes to scientific knowledge but also has potential implications for developing therapeutic approaches in veterinary medicine. Through his endeavors at Hitachi Chemical Company, Ltd., and collaboration with fellow researchers, Takagi continues to make significant strides in the advancement of equine health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile